BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 10632959)

  • 1. Recognition, diagnosis, and management of Wilson's disease.
    Brewer GJ
    Proc Soc Exp Biol Med; 2000 Jan; 223(1):39-46. PubMed ID: 10632959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical recommendations and new therapies for Wilson's disease.
    Brewer GJ
    Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathogenesis and treatment of Wilson's disease].
    Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
    Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment.
    Brewer GJ
    CNS Drugs; 2005; 19(3):185-92. PubMed ID: 15740174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilson's disease.
    Ala A; Walker AP; Ashkan K; Dooley JS; Schilsky ML
    Lancet; 2007 Feb; 369(9559):397-408. PubMed ID: 17276780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of Wilson's disease, a rare genetic disorder of copper metabolism.
    Purchase R
    Sci Prog; 2013; 96(Pt 1):19-32. PubMed ID: 23738435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Drug Managements of Wilson's Disease: From West to East.
    Li WJ; Chen C; You ZF; Yang RM; Wang XP
    Curr Neuropharmacol; 2016; 14(4):322-5. PubMed ID: 26639459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?
    Schilsky ML
    Curr Gastroenterol Rep; 2001 Feb; 3(1):54-9. PubMed ID: 11177695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel therapeutic approaches to the treatment of Wilson's disease.
    Brewer GJ
    Expert Opin Pharmacother; 2006 Feb; 7(3):317-24. PubMed ID: 16448326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of Wilson's disease.
    Subramanian I; Vanek ZF; Bronstein JM
    Curr Neurol Neurosci Rep; 2002 Jul; 2(4):317-23. PubMed ID: 12044251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical considerations for an effective medical therapy in Wilson's disease.
    Weiss KH; Stremmel W
    Ann N Y Acad Sci; 2014 May; 1315():81-5. PubMed ID: 24754532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wilson's Disease: A Review for the General Pediatrician.
    Capone K; Azzam RK
    Pediatr Ann; 2018 Nov; 47(11):e440-e444. PubMed ID: 30423186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study.
    Merle U; Schaefer M; Ferenci P; Stremmel W
    Gut; 2007 Jan; 56(1):115-20. PubMed ID: 16709660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wilson's disease treatment by triethylene tetramine dihydrochloride (trientine, 2HCl): long-term observations.
    Morita J; Yoshino M; Watari H; Yoshida I; Motohiro T; Yamashita F; Okano Y; Hashimoto T
    Dev Pharmacol Ther; 1992; 19(1):6-9. PubMed ID: 1307347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of presymptomatic Wilson's disease.
    Walshe JM
    Lancet; 1988 Aug; 2(8608):435-7. PubMed ID: 2900362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to treatment, a challenge even in treatable metabolic rare diseases: A cross sectional study of Wilson's disease.
    Jacquelet E; Poujois A; Pheulpin MC; Demain A; Tinant N; Gastellier N; Woimant F
    J Inherit Metab Dis; 2021 Nov; 44(6):1481-1488. PubMed ID: 34480375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mode of action of triethylenetetramine dihydrochloride on copper metabolism in Wilson's disease.
    Siegemund R; Lössner J; Günther K; Kühn HJ; Bachmann H
    Acta Neurol Scand; 1991 Jun; 83(6):364-6. PubMed ID: 1887758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Wilson's disease with severe neurological manifestations: response to trientine plus zinc therapy].
    Serra B; Primo J; García M; Amorós I; Aragó M; Merino C
    Gastroenterol Hepatol; 2004 May; 27(5):307-10. PubMed ID: 15117609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wilson's disease--treatment of psychiatric manifestations in pregnancy.
    Rich AM; Lajoie TM
    Psychosomatics; 2012; 53(2):175-7. PubMed ID: 22424165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.